MEDFORD, Ore.--(BUSINESS WIRE)--Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with operations and assets in Oregon and Michigan, today announced record revenues for its Mic
Frederic Ors to Step Down as CEO CBO Andrew Hall Appointed Interim CEO Board Initiating Search for Permanent Successor DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq:IMV; TSX:IMV) (“IMV” or the “Company”), a clinical-stage biopharmac
Dr. Barry Duplantis, Ph.D., promoted to VP of Client Relations Carla Dahl, appointed to VP of Marketing VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VEN
Collaboration leverages AbCellera’s AI-powered technology platform to identify novel antibody drug candidates for multiple disease targets across several therapeutic areas coupled with EQRx’s innovative model to accelerate the delivery and patient ac
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LL
MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, fo
BURLINGTON, Ontario--(BUSINESS WIRE)--$ANRG #Anaergia--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today the acquisition of its indirect subsidiary, Rhode Island Bioenergy Facility, LLC (fka Orbit Energy Rhode Island, LLC), w
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB: CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therape
TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) is pleased to announce the appointment of Robert Higgins to the board of directors of the Company (the “Board”), effective immediately. The
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that Janssen Biotech, Inc. (Janssen) dosed the first patient with JNJ-7827834
Hello from the Vermillion Growers Team in Dauphin. We are thrilled to share some updates on the progress of the greenhouse build. The most visible and most exciting update is that the powder coated steel for the greenhouse structure is going up!
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.